Terms: = Colorectal cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7
827 results:
1. Colonic lymphomatous polyposis mantle cell lymphoma: a case report and review of literature.
Djiwa T; Koui BBS; Aman NA; Coulibaly ZI; Kouyate M; Kouame KE
J Med Case Rep; 2024 May; 18(1):219. PubMed ID: 38698463
[TBL] [Abstract] [Full Text] [Related]
2. Temporal trends and regional variability in BRAF and KRAS genetic testing in Denmark (2010-2022): Implications for precision medicine.
Frost MG; Jensen KJ; Jimenez-Solem E; Qvortrup C; Kuhlmann TP; Andersen JL; Høgdall E; Petersen TS
Genes Chromosomes Cancer; 2024 Apr; 63(4):e23236. PubMed ID: 38656617
[TBL] [Abstract] [Full Text] [Related]
3. Decoding the Versatile Landscape of Autophagic Protein VMP1 in cancer: A Comprehensive Review across Tissue Types and Regulatory Mechanisms.
Renna FJ; Gonzalez CD; Vaccaro MI
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612567
[TBL] [Abstract] [Full Text] [Related]
4. Compound 225# inhibits the proliferation of human colorectal cancer cells by promoting cell cycle arrest and apoptosis induction.
Zhang X; He L; Li Y; Qiu Y; Hu W; Lu W; Du H; Yang D
Oncol Rep; 2024 May; 51(5):. PubMed ID: 38577924
[TBL] [Abstract] [Full Text] [Related]
5. Discovery of novel urea derivatives as ferroptosis and autophagy inducer for human colon cancer treatment.
Liang T; Dong H; Wang Z; Lu L; Song X; Qi J; Zhang Y; Wang J; Du G
Eur J Med Chem; 2024 Mar; 268():116277. PubMed ID: 38422700
[TBL] [Abstract] [Full Text] [Related]
6. Musashi-2 potentiates colorectal cancer immune infiltration by regulating the post-translational modifications of HMGB1 to promote DCs maturation and migration.
Meng X; Na R; Peng X; Li H; Ouyang W; Zhou W; You X; Li Y; Pu X; Zhang K; Xia J; Wang J; Tang H; Zhuang G; Peng Z
Cell Commun Signal; 2024 Feb; 22(1):117. PubMed ID: 38347600
[TBL] [Abstract] [Full Text] [Related]
7. [Treatment Strategy for Familial Adenomatous Polyposis Presenting with Obstructive colorectal cancer and Concurrent Liver Metastasis].
Yoshida K; Ushigome M; Yamazaki N; Yamakawa T; Miura Y; Suzuki T; Kagami S; Kaneko T; Kurihara A; Tochigi N; Funahashi K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1396-1398. PubMed ID: 38303286
[TBL] [Abstract] [Full Text] [Related]
8. [A Case of Conversion Surgery after Chemotherapy for Unresectable Liver Metastasis of Rectal cancer].
Umezu M; Goto K; Tokuyama S; Sakai K; Toshiyama R; Kawai K; Takahashi Y; Hamakawa T; Doi T; Takeno A; Kato T; Takami K; Hirao M
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1789-1791. PubMed ID: 38303208
[TBL] [Abstract] [Full Text] [Related]
9. Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis.
Frei AL; McGuigan A; Sinha RRAK; Jabbar F; Gneo L; Tomasevic T; Harkin A; Iveson T; Saunders MP; Oien KA; Maka N; Pezzella F; Campo L; Browne M; Glaire M; Kildal W; Danielsen HE; Hay J; Edwards J; Sansom O; Kelly C; Tomlinson I; Kerr R; Kerr D; Domingo E; ; Church DN; Koelzer VH
Lancet Oncol; 2024 Feb; 25(2):198-211. PubMed ID: 38301689
[TBL] [Abstract] [Full Text] [Related]
10. scRNA-seq of colorectal cancer shows regional immune atlas with the function of cd20
Ji L; Fu G; Huang M; Kao X; Zhu J; Dai Z; Chen Y; Li H; Zhou J; Chu X; Lei Z
Cancer Lett; 2024 Mar; 584():216664. PubMed ID: 38253219
[TBL] [Abstract] [Full Text] [Related]
11. New Rare Triterpene Glycosides from Pacific Sun Star,
Malyarenko TV; Kicha AA; Kuzmich AS; Malyarenko OS; Kalinovsky AI; Popov RS; Dmitrenok PS; Ivanchina NV; Stonik VA
Mar Drugs; 2023 Dec; 22(1):. PubMed ID: 38248644
[TBL] [Abstract] [Full Text] [Related]
12. The Role of High Mobility Group Box B-1 in the Prognosis of colorectal cancer Based on the Changes in the Intestinal Mucosal Barrier.
Zhao W; Chen A; Yuan N; Hao X; Wang C; Lu X; Song X; Zhang Z
Technol Cancer Res Treat; 2024; 23():15330338231198972. PubMed ID: 38200714
[No Abstract] [Full Text] [Related]
13. SNRPB promotes the progression of hepatocellular carcinoma via regulating cell cycle, oxidative stress, and ferroptosis.
Wang X; Zhang H; Guo Z; Wang J; Lu C; Wang J; Jin R; Mo Z
Aging (Albany NY); 2024 Jan; 16(1):348-366. PubMed ID: 38189879
[TBL] [Abstract] [Full Text] [Related]
14. Repurposing Metabolic Inhibitors in the Treatment of Colon Adenocarcinoma Patient-Derived Models.
Lee B; Lee C; Moon HM; Jo SY; Jang SJ; Suh YA
Cells; 2023 Dec; 12(24):. PubMed ID: 38132178
[TBL] [Abstract] [Full Text] [Related]
15. Naturally nutrient rich (NNR) score and the risk of colorectal cancer: a case-control study.
Hassanpour Ardekanizadeh N; Mousavi Mele M; Mohammadi S; Shekari S; Zeinalabedini M; Masoumvand M; Mousavi Shalmani SH; Askarpour SA; Gholamalizadeh M; Vahid F; Doaei S
BMJ Open Gastroenterol; 2023 Dec; 10(1):. PubMed ID: 38050374
[TBL] [Abstract] [Full Text] [Related]
16. Opposing roles by KRAS and BRAF mutation on immune cell infiltration in colorectal cancer - possible implications for immunotherapy.
Edin S; Gylling B; Li X; Stenberg Å; Löfgren-Burström A; Zingmark C; van Guelpen B; Ljuslinder I; Ling A; Palmqvist R
Br J Cancer; 2024 Jan; 130(1):143-150. PubMed ID: 38040818
[TBL] [Abstract] [Full Text] [Related]
17. Elevated expression of CXCL3 in colon cancer promotes malignant behaviors of tumor cells in an ERK-dependent manner.
Cheng Y; Yang X; Liang L; Xin H; Dong X; Li W; Li J; Guo X; Li Y; He J; Zhang C; Wang W
BMC Cancer; 2023 Nov; 23(1):1162. PubMed ID: 38031087
[TBL] [Abstract] [Full Text] [Related]
18. RPF2 mediates the CARM1‑MYCN axis to promote chemotherapy resistance in colorectal cancer cells.
Lu M; Hu X; Cheng C; Zhang Y; Huang L; Kong X; Li Z; Zhang Q; Zhang Y
Oncol Rep; 2024 Jan; 51(1):. PubMed ID: 37997821
[TBL] [Abstract] [Full Text] [Related]
19. Improvement of Severe Colon Stricture after Rituximab Therapy for Concomitant Mucosa-associated Lymphoid Tissue Lymphoma in a Patient with Ulcerative Colitis.
Park HJ; Moon W; Park SJ; Park MI; Kim SE; Kim JH; Jung K; Seo KI; Lee EM; Jung M
Korean J Gastroenterol; 2023 Nov; 82(5):254-260. PubMed ID: 37997222
[TBL] [Abstract] [Full Text] [Related]
20. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
Sohel M
Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
[TBL] [Abstract] [Full Text] [Related]
[Next]
